The Bench to Bedside Eye Pitch submission process is now open. Submit your idea.
The Bench to Bedside (B2B) Organizing Committee seeks submissions of great ideas for new treatments, drugs or devices to be pitched to a panel of experts during the inaugural Bench to Bedside Meeting in Baltimore, Md. If you have an entrepreneurial mindset and little to no experience moving an idea forward through the pipeline, this session is for you.
If your pitch is selected, you will take part in a learning session with a panel of expert where you will present your 5-7-minute pitch for feedback.
At the end of the pitch session the expert panel and the submitters will take part in a Q&A with the audience.
Pitch submission eligibility
Anyone with a great idea for a new treatment, drug or device in eye and vision research can submit a pitch. The organizing committee is especially interested in hearing about ideas and products early to mid in the development pipeline. Submitters do not need to be ARVO members but are expected to attend the B2B Meeting and present the work if selected. Everyone can submit one idea for consideration.
Note: The committee expects that any ideas being presented are already protected by any appropriate patent applications.
Key dates for the 2020 B2B Program
Dec. 2, 2019 Pitch submission site opens
Jan. 22, 2020 Pitch submission deadline
Feb. 13, 2020 Pitch acceptance and scheduling notification sent to Submitter